These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2195734)

  • 1. [Immunosuppression with cyclosporin induces clinical remission and improved beta cell function in patients with newly diagnosed insulin-dependent diabetes. A national and international multicenter study].
    Mandrup-Poulsen TR; Mølvig JC; Andersen V; Bendtzen K; Binder C; Brøns M; d'Amore FA; Dieperink H; Enk B; Frandsen NE
    Ugeskr Laeger; 1990 Jul; 152(27):1963-9. PubMed ID: 2195734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of cyclosporin A therapy in the early phase of type I diabetes mellitus].
    Schernthaner G; Aschauer-Treiber G; Gaube S; Klösch-Kasparek D; Müller C; Zielinski C
    Wien Klin Wochenschr; 1988 Jun; 100(13):454-9. PubMed ID: 3043916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients. The Canadian-European Randomized Control Trial Group.
    Mandrup-Poulsen T; Mølvig J; Andersen HU; Helqvist S; Spinas GA; Munck M
    Diabetes; 1990 Feb; 39(2):204-10. PubMed ID: 2227128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials of cyclosporin in IDDM.
    Dupré J; Stiller CR; Gent M; Donner A; von Graffenried B; Heinrichs D; Jenner M; Keown P; Mahon J; Martell R
    Diabetes Care; 1988; 11 Suppl 1():37-44. PubMed ID: 3069390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.
    Keymeulen B; Vandemeulebroucke E; Ziegler AG; Mathieu C; Kaufman L; Hale G; Gorus F; Goldman M; Walter M; Candon S; Schandene L; Crenier L; De Block C; Seigneurin JM; De Pauw P; Pierard D; Weets I; Rebello P; Bird P; Berrie E; Frewin M; Waldmann H; Bach JF; Pipeleers D; Chatenoud L
    N Engl J Med; 2005 Jun; 352(25):2598-608. PubMed ID: 15972866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.
    Charles MA; Suzuki M; Waldeck N; Dodson LE; Slater L; Ong K; Kershnar A; Buckingham B; Golden M
    J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of methylprednisolone pulse therapy on insulin injections in patients with insulin-dependent diabetes mellitus.
    Satman I; Fiçicioğlu C; Karşidağ K; Yilmaz T; Dinçdağ N; Koca F; Odabaşi F; Aydin A; Devrim S; Haktan M
    Turk J Pediatr; 1996; 38(4):419-29. PubMed ID: 8993171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic islet cell autoantibodies in newly diagnosed insulin-dependent diabetes mellitus: lack of correlation to age, residual beta cell function, HLA antigens and Coxsackie B virus antibodies.
    Hehmke B; Michaelis D; Hildmann W; Richter KV; Kohnert KD
    Diabetes Res; 1987 Feb; 4(2):73-7. PubMed ID: 3034475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and aetiological classification of insulin-dependent diabetes in the elderly.
    Kilvert A; Fitzgerald MG; Wright AD; Nattrass M
    Q J Med; 1986 Sep; 60(233):865-72. PubMed ID: 3306756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of two periods with intensified insulin treatment on B-cell function during the first 18 months of type 1 (insulin-dependent) diabetes mellitus.
    Krarup T; Madsbad S
    Diabete Metab; 1986 Oct; 12(5):256-60. PubMed ID: 3542618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
    Hummel M; Durinovic-Bello I; Ziegler AG
    J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of beta-cell function and remission in recent-onset IDDM after cyclosporin treatment. The Canadian-European Randomized Control Trial Group.
    Petersen JS; Dyrberg T; Karlsen AE; Mølvig J; Michelsen B; Nerup J; Mandrup-Poulsen T
    Diabetes; 1994 Nov; 43(11):1291-6. PubMed ID: 7926302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Induction of remissions of insulin-dependent diabetes by cyclosporin].
    Feutren G; Papoz L; Assan R; Vialettes B; Pehuet M; Vexiau P; Durostu H; Rodier M; Sirmai J; Lallemand A
    C R Acad Sci III; 1986; 303(8):295-7. PubMed ID: 3094846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients.
    Ribi C; Cohen P; Pagnoux C; Mahr A; Arène JP; Lauque D; Puéchal X; Letellier P; Delaval P; Cordier JF; Guillevin L;
    Arthritis Rheum; 2008 Feb; 58(2):586-94. PubMed ID: 18240234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cyclosporin A treatment on the production of antibody in insulin-dependent (type I) diabetic patients.
    Boitard C; Feutren G; Castano L; Debray-Sachs M; Assan R; Hors J; Bach JF
    J Clin Invest; 1987 Dec; 80(6):1607-12. PubMed ID: 3316278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal weight promotes remission and low number of islet antibodies prolong the duration of remission in Type 1 diabetes.
    Schölin A; Törn C; Nyström L; Berne C; Arnqvist H; Blohmé G; Bolinder J; Eriksson JW; Kockum I; Landin-Olsson M; Ostman J; Karlsson FA; Sundkvist G; Björk E
    Diabet Med; 2004 May; 21(5):447-55. PubMed ID: 15089789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autoantibodies against islet cell antigens and type 1 diabetes after treatment with interferon-alpha].
    Schories M; Peters T; Rasenack J; Reincke M
    Dtsch Med Wochenschr; 2004 May; 129(20):1120-4. PubMed ID: 15143453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
    Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
    Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus.
    Silverstein J; Maclaren N; Riley W; Spillar R; Radjenovic D; Johnson S
    N Engl J Med; 1988 Sep; 319(10):599-604. PubMed ID: 3045545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.